ATE207753T1 - Wundheilmittel - Google Patents

Wundheilmittel

Info

Publication number: ATE207753T1
Authority: AT; Austria
Prior art keywords: pct; chitosan; polysaccharide; composition; heparin
Prior art date: 1994-07-19

Application number

AT95926574T

Other languages

English (en)

Inventor

Ibrahim Gouda

Olle Larm

Original Assignee

Medicarb Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-19

Filing date

1995-07-18

Publication date

2001-11-15

1995-07-18 Application filed by Medicarb Ab filed Critical Medicarb Ab

2001-11-15 Application granted granted Critical

2001-11-15 Publication of ATE207753T1 publication Critical patent/ATE207753T1/de

Links

229920001661 Chitosan Polymers 0.000 abstract 4
229920002971 Heparan sulfate Polymers 0.000 abstract 4
150000004676 glycans Chemical class 0.000 abstract 3
229920001282 polysaccharide Polymers 0.000 abstract 3
239000005017 polysaccharide Substances 0.000 abstract 3
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 2
206010052428 Wound Diseases 0.000 abstract 2
208000027418 Wounds and injury Diseases 0.000 abstract 2
229960002897 heparin Drugs 0.000 abstract 2
238000006640 acetylation reaction Methods 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
230000002500 effect on skin Effects 0.000 abstract 1
230000035876 healing Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1
230000029663 wound healing Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Materials Engineering (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Materials For Medical Uses (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Media Introduction/Drainage Providing Device (AREA)
Magnetic Resonance Imaging Apparatus (AREA)
Surgical Instruments (AREA)

AT95926574T 1994-07-19 1995-07-18 Wundheilmittel ATE207753T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9402531A SE9402531L (sv)	1994-07-19	1994-07-19	Sårläkningsmedel
PCT/SE1995/000875 WO1996002260A1 (en)	1994-07-19	1995-07-18	Wound healing agent

Publications (1)

Publication Number	Publication Date
ATE207753T1 true ATE207753T1 (de)	2001-11-15

Family

ID=20394771

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95926574T ATE207753T1 (de)	1994-07-19	1995-07-18	Wundheilmittel

Country Status (11)

Country	Link
US (1)	US5902798A (de)
EP (1)	EP0759760B1 (de)
JP (1)	JP3337472B2 (de)
AT (1)	ATE207753T1 (de)
AU (1)	AU691322B2 (de)
CA (1)	CA2194976C (de)
DE (1)	DE69523585T2 (de)
DK (1)	DK0759760T3 (de)
ES (1)	ES2161903T3 (de)
SE (1)	SE9402531L (de)
WO (1)	WO1996002260A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5576839A (en) *	1991-09-25	1996-11-19	Minolta Camera Kabushiki Kaisha	Camera system including a separatable recorder
SE508760C2 (sv)	1997-04-29	1998-11-02	Medicarb Ab	Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
NL1011680C2 (nl)	1999-03-26	2000-09-27	Nutricia Nv	Voedingssamenstellen die licht negatief geladen, niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
US6391334B1 (en)	1999-10-25	2002-05-21	Amway Corporation	Barrier-forming composition
ES2491866T3 (es) *	1999-11-15	2014-09-08	Piramal Healthcare (Canada) Limited	Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH
AU1848601A (en) *	1999-12-09	2001-06-18	Bio Syntech Canada Inc	Mineral-polymer hybrid composition
US20030158302A1 (en) *	1999-12-09	2003-08-21	Cyric Chaput	Mineral-polymer hybrid composition
GB9929472D0 (en) *	1999-12-13	2000-02-09	Btg Int Ltd	Polymeric film
US20020082220A1 (en) *	2000-06-29	2002-06-27	Hoemann Caroline D.	Composition and method for the repair and regeneration of cartilage and other tissues
DE60125973D1 (de) *	2000-11-15	2007-02-22	Biosyntech Canada Inc	Verfahren zur wiederherstellung einer geschädigten bandscheibe
US6623761B2 (en)	2000-12-22	2003-09-23	Hassan Emadeldin M.	Method of making nanoparticles of substantially water insoluble materials
KR20020066024A (ko) *	2001-02-08	2002-08-14	굿젠 주식회사	수용성 키토산과 헤파린으로 이루어진 상처 치유 촉진연고 조성물과 필름 및 제품
US7153492B2 (en)	2001-04-12	2006-12-26	Medicarb Ab	Effervescent solid composition of matter
SE522529C2 (sv)	2001-04-12	2004-02-17	Medicarb Ab	Effervescent fastämneskomposition innefattande som aktiv komponent kitosan, dess derivat och salter därav, användning samt framställning därav
US7297343B2 (en) *	2001-07-31	2007-11-20	Biosurface Engineering Technologies, Inc.	Bioactive medical films
KR20020060627A (ko) *	2002-01-16	2002-07-18	조석형	키토산/음이온성 다당류의 창상 치유제
AU2003215280A1 (en)	2002-02-15	2003-09-09	Northwestern University	Self-assembly of peptide-amphiphile nanofibers under physiological conditions
CA2493083C (en) *	2002-07-16	2012-11-06	Bio Syntech Canada Inc.	Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
US7554021B2 (en)	2002-11-12	2009-06-30	Northwestern University	Composition and method for self-assembly and mineralization of peptide amphiphiles
US20070053848A1 (en) *	2003-08-26	2007-03-08	Stockel Richard F	Antimicrobial materials for dental care applications
JP2006347883A (ja) *	2003-09-08	2006-12-28	Neetec:Kk	糖鎖含有キトサン誘導体及びグリコサミノグリカンを含有する医療用組成物
ATE541580T1 (de)	2003-12-05	2012-02-15	Univ Northwestern	Selbst anordnende peptid-amphiphile und relevante verfahren für die abgabe von wachstumsfaktor
US20050136024A1 (en) *	2003-12-22	2005-06-23	Stockel Richard F.	Dermatological compositions
US20070086977A1 (en) *	2003-12-22	2007-04-19	Stockel Richard F	Method of treating dermatological conditions
US20050283004A1 (en) *	2004-06-18	2005-12-22	Hopax Chemicals Manufacturing Co., Ltd.	Alkylsulfonated polyaminosaccharides
CA2598251A1 (en) *	2005-03-04	2006-09-14	Northwestern University	Angiogenic heparin binding peptide amphiphiles
WO2007051311A1 (en) *	2005-11-04	2007-05-10	Bio Syntech Canada Inc.	Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
DE102006020035A1 (de) *	2006-04-26	2007-10-31	B. Braun Melsungen Ag	Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
EP1958613A1 (de) *	2007-02-15	2008-08-20	Polichem S.A.	Dermale filmbildende flüssige Formulierungen zur Wirkstofffreisetzung auf der Haut
US8076295B2 (en)	2007-04-17	2011-12-13	Nanotope, Inc.	Peptide amphiphiles having improved solubility and methods of using same
DK2195039T3 (en)	2007-08-28	2017-01-30	Otago Innovation Ltd	SURGICAL HYDROGEL
US9440099B2 (en) *	2008-11-20	2016-09-13	Laboratori Derivati Organici Spa	Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations
RU2519225C2 (ru) *	2008-12-06	2014-06-10	Б. Браун Мельзунген Аг	Опосредующие транспорт коллоидные лекарственные соединения
US9018372B2 (en)	2009-03-31	2015-04-28	B. Braun Melsungen Ag	Bonding products of aminated polysaccharides
WO2010120830A1 (en)	2009-04-13	2010-10-21	Northwestern University	Novel peptide-based scaffolds for cartilage regeneration and methods for their use
US8906883B2 (en) *	2009-06-10	2014-12-09	Exthera Ab	Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
EP2473201B1 (de)	2009-09-01	2016-08-10	Medovent GmbH	Gewebeauflage aus chitosan
KR20130018739A (ko)	2010-03-03	2013-02-25	네오큐티스 에스아	항균 펩티드 격리 화합물을 사용한 피부 질환 및 장애의 치료를 위한 조성물 및 방법
CN105451745B (zh)	2013-08-13	2018-03-27	生化学工业株式会社	含有阳离子化壳聚糖的药物
US9192574B2 (en)	2013-10-24	2015-11-24	Medtronic Xomed, Inc.	Chitosan paste wound dressing
US9192692B2 (en)	2013-10-24	2015-11-24	Medtronic Xomed, Inc.	Chitosan stenting paste
FR3016882A1 (fr)	2014-01-30	2015-07-31	Sofradim Production	Procede de preparation de chitosane a haut degre d’acetylation
US10126298B2 (en)	2015-05-04	2018-11-13	Arman Nabatian	Hydrogels containing embedded substrates for targeted binding of molecules
US9248160B1 (en) *	2015-07-28	2016-02-02	Zo Skin Health, Inc.	Post-procedure skin care systems, compositions, and methods of use thereof
KR102712081B1 (ko) *	2018-01-12	2024-10-02	보스톤 싸이엔티픽 싸이메드 인코포레이티드	지혈을 달성하기 위한 분말
EP3787593A1 (de)	2018-05-04	2021-03-10	Bonoss Medical Aktiebolag	Zusammensetzung zur verminderung der narbenbildung
FR3150119B1 (fr) *	2023-06-20	2026-03-13	Oreal	Composition à base de chitosan et d’un polysaccharide modifié

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4378017A (en) *	1980-03-21	1983-03-29	Kureha Kagaku Kogyo Kabushiki Kaisha	Composite material of de-N-acetylated chitin and fibrous collagen
US4326532A (en) *	1980-10-06	1982-04-27	Minnesota Mining And Manufacturing Company	Antithrombogenic articles
US4532134A (en) *	1981-04-06	1985-07-30	Malette William Graham	Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US5002582A (en) *	1982-09-29	1991-03-26	Bio-Metric Systems, Inc.	Preparation of polymeric surfaces via covalently attaching polymers
CA1202904A (en) *	1983-11-21	1986-04-08	Brian G. Sparkes	Chitosan based wound dressing materials
JPS61253065A (ja) *	1985-05-02	1986-11-10	片倉チツカリン株式会社	キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法
US4879282A (en) *	1987-03-17	1989-11-07	Saliba Jr Michael J	Medical application for heparin and related molecules
US5037810A (en) *	1987-03-17	1991-08-06	Saliba Jr Michael J	Medical application for heparin and related molecules
DE4200080A1 (de) *	1992-01-03	1993-09-30	Reinmueller Johannes	Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
JP3205104B2 (ja) *	1992-01-20	2001-09-04	川研ファインケミカル株式会社	化粧料
SE9402529D0 (sv) *	1994-07-19	1994-07-19	Astra Ab	Anti-adherensmedel

1994
- 1994-07-19 SE SE9402531A patent/SE9402531L/xx not_active Application Discontinuation
1995
- 1995-07-18 WO PCT/SE1995/000875 patent/WO1996002260A1/en not_active Ceased
- 1995-07-18 ES ES95926574T patent/ES2161903T3/es not_active Expired - Lifetime
- 1995-07-18 AT AT95926574T patent/ATE207753T1/de not_active IP Right Cessation
- 1995-07-18 EP EP95926574A patent/EP0759760B1/de not_active Expired - Lifetime
- 1995-07-18 CA CA002194976A patent/CA2194976C/en not_active Expired - Fee Related
- 1995-07-18 AU AU30902/95A patent/AU691322B2/en not_active Ceased
- 1995-07-18 DE DE69523585T patent/DE69523585T2/de not_active Expired - Lifetime
- 1995-07-18 US US08/765,353 patent/US5902798A/en not_active Expired - Lifetime
- 1995-07-18 DK DK95926574T patent/DK0759760T3/da active
- 1995-07-18 JP JP50496696A patent/JP3337472B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK0759760T3 (da)	2001-11-26
SE9402531L (sv)	1996-01-20
AU3090295A (en)	1996-02-16
CA2194976A1 (en)	1996-02-01
JPH10502665A (ja)	1998-03-10
US5902798A (en)	1999-05-11
JP3337472B2 (ja)	2002-10-21
EP0759760A1 (de)	1997-03-05
DE69523585D1 (de)	2001-12-06
EP0759760B1 (de)	2001-10-31
AU691322B2 (en)	1998-05-14
ES2161903T3 (es)	2001-12-16
WO1996002260A1 (en)	1996-02-01
CA2194976C (en)	2002-04-30
DE69523585T2 (de)	2002-04-11
SE9402531D0 (sv)	1994-07-19

Legal Events

Date	Code	Title	Description
2002-02-15	UEP	Publication of translation of european patent specification
2004-04-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE207753T1 (de)	2001-11-15	Wundheilmittel
EP0815144A4 (de)	2001-01-10	Verfahren zur herstellung von glucan und therapeutische verwendung von glucan
KR970704459A (ko)	1997-09-06	경조직 자극제(Hard Tissue Stimulating Agent)
NO20035569D0 (no)	2003-12-12	Sårbandasje og metode for kontroll av livstruende bl degree dning
UA41989C2 (uk)	2001-10-15	Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
CA2266811A1 (en)	2000-09-25	Method and composition for wound treatment
NZ290218A (en)	1999-02-25	Composition to reduce adhesion in wound healing
CA2070685A1 (en)	1991-06-20	Method for treating painful, inflammatory or allergic disorders
RU97102350A (ru)	1999-02-27	Анти-адгезионный агент
PT1017403E (pt)	2006-07-31	Utilizacao de hialuronato de zinco contra a ulcera peptica
DE69702862D1 (de)	2000-09-21	Verwendung von sulfatierten polysacchariden zur behandlung einer chronischer verletzung
ATE214272T1 (de)	2002-03-15	Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DK0921806T3 (da)	2003-12-08	Mannose-6-phosphat-præparat og anvendelse deraf til behandling af fibrøse lidelser
BR9407669A (pt)	1997-01-28	Bandagem de ferida que compreende alginato
ATE251462T1 (de)	2003-10-15	Verfahren zur behandlung von narbengewebe
EA199800819A1 (ru)	1999-02-25	Способ лечения биполярного расстройства
PT751775E (pt)	2002-10-31	Derivados de mercaptoacetilamida hipocolesterolemicos, antiateroscleroticos e hipotrigliceridemicos
ATE202922T1 (de)	2001-07-15	Ophthalmische cromolyn-gelzubereitung
ATE189392T1 (de)	2000-02-15	Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten